Among the distinct subtypes of breast cancer, triple-negative breast cancer (TNBC) accounts for approximately 15%, and is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression [2]. This evidence concerns the gene PGR and breast carcinoma.